Biotech Values

[Biowatch]

GTCB from PR "On the basis of recent conversations, GTC understands that the CHMP, after excluding data from pregnant patients, determined that an insufficient number of surgical patients were enrolled to support approval."

I'd think it would be much easier to predict when you would get pregnant patients (hence easier to recruit) than surgery patients. Seems like they raised the bar.

Oh well. My portfolio took a hit today.